keyword
MENU ▼
Read by QxMD icon Read
search

Omeprazol and gastric cancer

keyword
https://www.readbyqxmd.com/read/29178442/the-effect-of-food-or-omeprazole-on-the-pharmacokinetics-of-osimertinib-in-patients-with-non-small-cell-lung-cancer-and-in-healthy-volunteers
#1
Karthick Vishwanathan, Paul A Dickinson, Khanh Bui, Philippe A Cassier, Alastair Greystoke, Eleanor Lisbon, Victor Moreno, Karen So, Karen Thomas, Doris Weilert, Timothy A Yap, Ruth Plummer
Two phase 1, open-label studies assessed the impact of food or gastric pH modification (omeprazole) on the exposure and safety/tolerability of osimertinib and its metabolites. The food effect study was an open-label, 2-period crossover study in patients with advanced non-small-cell lung cancer, randomized into 2 treatment sequences: single-dose osimertinib 80 mg in a fed then fasted state or fasted then fed. The gastric pH study was an open-label, 2-period fixed sequence study assessing the effect of omeprazole on osimertinib exposure in healthy male volunteers...
November 26, 2017: Journal of Clinical Pharmacology
https://www.readbyqxmd.com/read/29050283/omeprazole-promotes-carcinogenesis-of-fore-stomach-in-mice-with-co-stimulation-of-nitrosamine
#2
Lei Huang, Dong-Jiang Qi, Wei He, A-Man Xu
OBJECTIVES: To investigate if oral omeprazole application induces cancers of fore and glandular stomach in mice. METHODS: A total of 66 eligible male mice were randomly divided into 6 groups, which were treated with control reagent, low (6 mg/kg) and high dose omeprazole (30 mg/kg), N-methyl-N'-nitro-N-nitrosoguanidine (MNNG, 100 mg/L water), and MNNG plus low and high dose omeprazole, respectively. After 24 weeks, concentrations of acid phosphatase (ACP) and N-acetyl-β-D-glucosaminidase(NAG) in serum and spleen was examined, and p21 and mTOR levels in stomach were detected...
September 19, 2017: Oncotarget
https://www.readbyqxmd.com/read/28801980/effects-of-proton-pump-inhibitors-and-famotidine-on-elimination-of-plasma-methotrexate-evaluation-of-drug-drug-interactions-mediated-by-organic-anion-transporter-3
#3
Katsuya Narumi, Yu Sato, Masaki Kobayashi, Ayako Furugen, Kumiko Kasashi, Takehiro Yamada, Takanori Teshima, Ken Iseki
Methotrexate (MTX) is an antifolate agent used in the treatment of numerous types of cancer, and eliminated by active tubular secretion via organic anion transporter 3 (OAT3). Gastric antisecretory drugs, such as proton pump inhibitors (PPIs) and histamine H2 receptor antagonists, are widely used among patients with cancer in clinical practice. The aim of the present study was to analyse the potential drug-drug interactions between MTX and gastric antisecretory drugs in high-dose MTX (HD-MTX) therapy. The impact of PPIs on the plasma MTX concentration on 73 cycles of HD-MTX therapy was analysed retrospectively in 43 patients...
December 2017: Biopharmaceutics & Drug Disposition
https://www.readbyqxmd.com/read/28545189/outcomes-of-a-randomized-controlled-trial-comparing-modified-high-dose-omeprazole-and-amoxicillin-triple-therapy-with-standard-triple-therapy-for-helicobacter-pylori-eradication
#4
Kitti Chunlertlith, Uaepong Limpapanasit, Pisaln Mairiang, Suda Vannaprasaht, Wichittra Tassaneeyakul, Apichat Sangchan, Kookwan Sawadpanich, Tanita Suttichaimongkol, Jamrus Pongpit, Moragot Pattarapongsin
Background: Helicobacter pylori (H. pylori) infection is related to peptic ulcer diseases and gastric cancer and eradication of H. pylori should be expected to decrease the risk of their development. Factors affecting H. pylori eradication are antibiotic resistance, CYP2C19 genotypes, drug regimen and patient compliance. Increment of omeprazole and amoxicillin dosage in clarithromycin-containing triple therapy regimen may overcome these problems and may be a better choice than the conventional clarithromycin-containing triple therapy regimen...
April 1, 2017: Asian Pacific Journal of Cancer Prevention: APJCP
https://www.readbyqxmd.com/read/28516058/comparison-of-amoxicillin-and-metronidazole-effect-on-three-drug-regimen-for-the-treatment-of-helicobacter-pylori-infection-in-children
#5
Karam-Ali Kasiri, Abolfazl Khoshdel, Afshin Karimi, Morteza Sedehi, Niloufar Kasiri
Helicobacter pylori is an important risk factor for chronic gastritis, peptic ulcer, and gastric cancer. Three-drug regimen is the first-line treatment for this infection, but the response rate to treatment varies in different geographical regions. This study was conducted to comparatively determine the effect of amoxicillin and metronidazole on three-drug regimen to treat H. pylori infection in 1-15-year-old children. This clinical trial was conducted on 82 patients aged 1-15 years with convenience sampling referring to the Endoscopy Unit of Hajar Hospital, Shahrekord...
April 2017: Journal of Advanced Pharmaceutical Technology & Research
https://www.readbyqxmd.com/read/28463797/olive-olea-europaea-leaf-methanolic-extract-prevents-hcl-ethanol-induced-gastritis-in-rats-by-attenuating-inflammation-and-augmenting-antioxidant-enzyme-activities
#6
Saleh Al-Quraishy, Mohamed S Othman, Mohamed A Dkhil, Ahmed Esmat Abdel Moneim
Gastritis is preponderantly characterized by inflammation of the lining epithelial layer and the chronic gastritis is considered as a pre-cancer lesion. For many centuries olive (Olea europaea) leaf has been used for its putative health potential, nonetheless, to date, the gastroprotective effects of olive leaves have not been studied yet. Hence, in this study we investigated whether olive leaf extract (OLE) could protect gastric mucosa against HCl/ethanol-induced gastric mucosal damage in rats. Hcl/ethanol administration caused significant damage to the gastric mucosa, as confirmed by gastric ulcer index and histological evaluation...
July 2017: Biomedicine & Pharmacotherapy, Biomédecine & Pharmacothérapie
https://www.readbyqxmd.com/read/27759625/high-efficacy-of-gemifloxacin-containing-therapy-in-helicobacter-pylori-eradication-a-pilot-empirical-second-line-rescue-therapy
#7
RANDOMIZED CONTROLLED TRIAL
Laleh Mahmoudi, Shohreh Farshad, Mehrdad Seddigh, Paria Mahmoudi, Fardad Ejtehadi, Ramin Niknam
BACKGROUND: Helicobacter pylori (H pylori) is a common gastric pathogen which is associated with chronic gastritis, peptic ulcer, and gastric cancer. It has worldwide distribution with higher incidence in developing countries. Gemifloxacin is a fluoroquinolone antibiotic with documented in vitro activity against H pylori. Considering that there is no clinical data to verify gemifloxacin efficacy in H pylori eradication, this pilot clinical trial was designed. METHODS: This prospective pilot study was performed during February 2014 to February 2015...
October 2016: Medicine (Baltimore)
https://www.readbyqxmd.com/read/27159208/helicobacter-pylori-clarithromycin-resistance-in-symptomatic-pediatric-patients-in-a-high-prevalence-country
#8
Carolina A Serrano, Miguel A Leon, Camila Palma, Macarena Vera, Caroll Hernandez, Paul R Harris
INTRODUCTION: Failure to eradicate Helicobacter pylori despite antibiotic treatment is generally attributed to increasing clarithromycin resistance conferred by point mutations in the 23S-rRNA gene or metronidazole resistance attributed to rdxA gene (HP0954) deletion in patients. Scarce data for pediatric population are available from developing countries. OBJECTIVES: The aim of the present study was to determine the presence of A2142G/C and A2143G mutations in the 23S-rRNA gene and/or rdxA gene (HP0954) deletion in a group of symptomatic H pylori-infected children recruited from an area with high infection rate and risk of gastric cancer...
March 2017: Journal of Pediatric Gastroenterology and Nutrition
https://www.readbyqxmd.com/read/26611765/quadruple-therapy-versus-standard-triple-therapy-for-eradication-of-helicobacter-pylori-in-kuwait
#9
RANDOMIZED CONTROLLED TRIAL
Mohamed Alboraie, Motaz Saad, Jaber Al-Ali, Mohammad Malik, Noha Asem, Imre Schmidt, Ahmad A Alfadhli
BACKGROUND AND STUDY AIMS: Chronic infection caused by Helicobacter pylori (H. pylori) is associated with chronic gastritis, peptic ulcer disease, and gastric cancer. Eradication of H. pylori reduces morbidity of chronic gastritis and incidence of gastric cancer in high-risk population. We aimed at testing the efficacy of clarithromycin-based triple therapy and bismuth-based quadruple therapy for eradicating H. pylori in patients with chronic gastritis in Kuwait. PATIENTS AND METHODS: A total of 218 dyspeptic patients from different countries who were proved to have chronic gastritis by endoscopy and gastric biopsy were enroled...
September 2015: Arab Journal of Gastroenterology: the Official Publication of the Pan-Arab Association of Gastroenterology
https://www.readbyqxmd.com/read/26171138/the-helicobacter-pylori-eradication-in-the-group-receiving-standard-dose-and-group-continue-taking-amoxicillin-for-4-weeks-a-clinical-trial-study
#10
Mohammad Javad Ehsani-Ardakani, Meghdad Sedaghat, Gyti Eslami, Hamid Mohaghegh Shalmani
AIM: The aim of this study was to evaluate the Helicobacter pylori eradication in the group receiving standard -dose twice a day for two weeks and continue taking amoxicillin for 4 weeks. BACKGROUND: Helicobacter pylori is the major etiological cause of chronic gastritis, gastric and duodenal ulcers, gastric cancer and lymphoma. Therefore, patients should be treated after diagnosis of H. pylori infection. PATIENTS AND METHODS: A total of 66 consecutive patients with rapid urease test during endoscopy or biopsy positive for H...
2015: Gastroenterology and Hepatology From Bed to Bench
https://www.readbyqxmd.com/read/26027226/-anaesthesia-and-intensive-care-during-intraoperative-intraperitoneal-hyperthermic-chemotherapy-in-patients-with-gastric-cancer-literature-review-and-own-clinical-experience
#11
REVIEW
V E Khoronenko, M M Shemetova, O V Drozhzhina, V M Khomyakov, D D Sobolev
UNLABELLED: Despite a steady decline in the incidence in recent decades, gastric cancer remains one of the most frequent causes of death from cancer in the world. By the time of diagnosis the tumor process is locally advanced or generalized in nearly 70% of patients that reduces the possibility of radical surgical treatment. Peritoneal carcinomatosis is a one of the main causes of treatment failure. There patients need complex treatment with cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy (IHIC) to improve the quality and duration of life...
January 2015: Anesteziologiia i Reanimatologiia
https://www.readbyqxmd.com/read/25986943/a-large-randomised-controlled-intervention-trial-to-prevent-gastric-cancer-by-eradication-of-helicobacter-pylori-in-linqu-county-china-baseline-results-and-factors-affecting-the-eradication
#12
RANDOMIZED CONTROLLED TRIAL
Kai-feng Pan, Lian Zhang, Markus Gerhard, Jun-ling Ma, Wei-dong Liu, Kurt Ulm, Jian-xi Wang, Lei Zhang, Yang Zhang, Monther Bajbouj, Lan-fu Zhang, Ming Li, Michael Vieth, Rui-yong Liu, Michael Quante, Le-hua Wang, Stepan Suchanek, Tong Zhou, Wei-xiang Guan, Roland Schmid, Meinhard Classen, Wei-cheng You
OBJECTIVE: To clarify the full range of benefits and adverse consequences of Helicobacter pylori eradication as a strategy for gastric cancer prevention, the community-based intervention trial was launched in Linqu County, China. DESIGN: A total of 184,786 residents aged 25-54 years were enrolled in this trial and received (13)C-urea breath test. H. pylori positive participants were assigned into two groups, either receiving a 10-day quadruple anti-H. pylori treatment or lookalike placebos together with a single dosage of omeprazole and bismuth...
January 2016: Gut
https://www.readbyqxmd.com/read/25857514/upper-gastrointestinal-physiology-and-diseases
#13
REVIEW
Helge L Waldum, Per M Kleveland, Reidar Fossmark
Nordic research on physiology and pathophysiology of the upper gastrointestinal tract has flourished during the last 50 years. Swedish surgeons and physiologists were in the frontline of research on the regulation of gastric acid secretion. This research finally led to the development of omeprazole, the first proton pump inhibitor. When Swedish physiologists developed methods allowing the assessment of acid secretion in isolated oxyntic glands and isolated parietal cells, the understanding of mechanisms by which gastric acid secretion is regulated took a great step forward...
June 2015: Scandinavian Journal of Gastroenterology
https://www.readbyqxmd.com/read/25853150/early-or-late-antibiotic-intervention-prevents-helicobacter-pylori-induced-gastric-cancer-in-a-mouse-model
#14
Songhua Zhang, Dong Soo Lee, Rhiannon Morrissey, Jose R Aponte-Pieras, Arlin B Rogers, Steven F Moss
H. pylori infection causes gastritis, peptic ulcers and gastric cancer. Eradicating H. pylori prevents ulcers, but to what extent this prevents cancer remains unknown, especially if given after intestinal metaplasia has developed. H. pylori infected wild-type (WT) mice do not develop cancer, but mice lacking the tumor suppressor p27 do so, thus providing an experimental model of H. pylori-induced cancer. We infected p27-deficient mice with H. pylori strain SS1 at 6-8 weeks of age. Persistently H. pylori-infected WT C57BL/6 mice served as controls...
April 10, 2015: Cancer Letters
https://www.readbyqxmd.com/read/25762530/prevention-of-chemically-induced-urinary-bladder-cancers-by-naproxen-protocols-to-reduce-gastric-toxicity-in-humans-do-not-alter-preventive-efficacy
#15
Ronald A Lubet, James M Scheiman, Ann Bode, Jonathan White, Lori Minasian, M Margaret Juliana, Daniel L Boring, Vernon E Steele, Clinton J Grubbs
The COX inhibitors (NSAID/Coxibs) are a major focus for the chemoprevention of cancer. The COX-2-specific inhibitors have progressed to clinical trials and have shown preventive efficacy in colon and skin cancers. However, they have significant adverse cardiovascular effects. Certain NSAIDs (e.g., naproxen) have a good cardiac profile, but can cause gastric toxicity. The present study examined protocols to reduce this toxicity of naproxen. Female Fischer-344 rats were treated weekly with the urinary bladder-specific carcinogen hydroxybutyl(butyl)nitrosamine (OH-BBN) for 8 weeks...
April 2015: Cancer Prevention Research
https://www.readbyqxmd.com/read/25521730/changes-in-the-first-line-helicobacter-pylori-eradication-rates-using-the-triple-therapy-a-multicenter-study-in-the-tokyo-metropolitan-area-tokyo-helicobacter-pylori-study-group
#16
Takashi Kawai, Shin'ichi Takahashi, Hidekazu Suzuki, Hitoshi Sasaki, Akihito Nagahara, Daisuke Asaoka, Takeshi Matsuhisa, Tatsuhiro Masaoaka, Toshihiro Nishizawa, Masayuki Suzuki, Masayoshi Ito, Naoto Kurihara, Fumio Omata, Shigeaki Mizuno, Akira Torii, Kohei Kawakami, Toshifumi Ohkusa, Kengo Tokunaga, Tetsuya Mine, Nobuhiro Sakaki
BACKGROUND AND AIM: Helicobacter pylori (H. pylori) infection is a strong risk factor for the development of gastric cancer. In 2013, the Japanese government approved H. pylori eradication therapy in patients with chronic gastritis as well as peptic ulcer. However, the continuing decline in eradication rates for first-line H. pylori eradication therapies is an urgent problem. In this study, we investigated changes in the first-line eradication rate from 2001 to 2010. METHODS: Eradication rates for 7-day triple therapy [proton pump inhibitor (rabeprazole 20 mg, lansoprazole 60 mg, or omeprazole 40 mg)+amoxicillin 1500 mg + clarithromycin (CAM) 400 or 800 mg, daily] were collated from 14 hospitals in the Tokyo metropolitan area...
December 2014: Journal of Gastroenterology and Hepatology
https://www.readbyqxmd.com/read/25246385/gastric-acid-suppression-is-associated-with-decreased-erlotinib-efficacy-in-non-small-cell-lung-cancer
#17
Michael P Chu, Sunita Ghosh, Carole R Chambers, Naveen Basappa, Charles A Butts, Quincy Chu, David Fenton, Anil A Joy, Randeep Sangha, Michael Smylie, Michael B Sawyer
BACKGROUND: Erlotinib is a key therapy for advanced NSCLC. Concurrent AS therapy with TKIs might reduce TKI plasma levels. Because of gastroesophageal reflux disease prevalence, this retrospective analysis was undertaken to determine if coadministering erlotinib with AS therapy affected NSCLC outcomes. PATIENTS AND METHODS: Records of advanced NSCLC patients who received erlotinib from 2007 to 2012 at a large, centralized, cancer institution were retrospectively reviewed...
January 2015: Clinical Lung Cancer
https://www.readbyqxmd.com/read/25218349/early-or-late-antibiotic-intervention-prevents-helicobacter-pylori-induced-gastric-cancer-in-a-mouse-model
#18
Songhua Zhang, Dong Soo Lee, Rhiannon Morrissey, Jose R Aponte-Pieras, Arlin B Rogers, Steven F Moss
H. pylori infection causes gastritis, peptic ulcers and gastric cancer. Eradicating H. pylori prevents ulcers, but to what extent this prevents cancer remains unknown, especially if given after intestinal metaplasia has developed. H. pylori infected wild-type (WT) mice do not develop cancer, but mice lacking the tumor suppressor p27 do so, thus providing an experimental model of H. pylori-induced cancer. We infected p27-deficient mice with H. pylori strain SS1 at 6-8 weeks of age. Persistently H. pylori-infected WT C57BL/6 mice served as controls...
December 1, 2014: Cancer Letters
https://www.readbyqxmd.com/read/25098924/efficacy-and-safety-of-1-week-helicobacter-pylori-eradication-therapy-and-7-week-rebamipide-treatment-after-endoscopic-submucosal-dissection-of-early-gastric-cancer-in-comparison-with-8-week-ppi-standard-treatment-a-randomized-controlled-prospective-multicenter
#19
RANDOMIZED CONTROLLED TRIAL
Kazuhide Higuchi, Toshihisa Takeuchi, Noriya Uedo, Yoji Takeuchi, Yuji Naito, Nobuaki Yagi, Kazunari Tominaga, Hirohisa Machida, Takashi Tamada, Yoshinori Morita, Shujiro Yazumi, Junichi Yamao, Mikitaka Iguchi, Takeshi Azuma
BACKGROUND: Endoscopic submucosal dissection (ESD) has been developed for early gastric cancer (EGC). Helicobacter pylori eradication therapy has been reported to have a preventive effect against metachronous recurrence of EGC after ESD. However, the efficacy and safety of eradication therapy on ESD-induced ulcer healing are not clear. In a randomized control study, we compared the standard therapy (8-week proton pump inhibitor) and eradication therapy combined with subsequent treatment with 7-week rebamipide for healing ESD-induced ulcers...
July 2015: Gastric Cancer
https://www.readbyqxmd.com/read/24985588/anti-helicobacter-pylori-effect-of-total-alkaloids-of-sophora-alopecuroides-in-vivo
#20
Aiping Tian, Ting Xu, Kaiyun Liu, Quanming Zou, Xiang Yan
BACKGROUND: Helicobacter pylori (H. pylori) infection could lead to most gastroduodenal diseases and is even identified as a carcinogen of gastric cancer. Total alkaloids of sophora alopecuroides (TASA) is widely used in herbal remedies to treat various infectious diseases, including stomach-associated diseases. This study is aimed at evaluating the antimicrobial activity of TASA on H. pylori-infected BALB/c mice mouse gastritis. METHODS: Totally 120 BALB/c mice were orally inoculated with H...
2014: Chinese Medical Journal
keyword
keyword
106269
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"